Seven months after announcing plans to merge, virtual care company Doctor on Demand and clinical navigator Grand Rounds are launching a new brand for their combined company.
Learn more about innovative solutions that can help you comply with new regulations.
Agency advisers unanimously supported offering a second dose of J&J’s coronavirus vaccine to adults who previously received it, though guidance could change as regulators evaluate mixing boosters.
Walgreens significantly invested in two companies to meet its long-term strategy, with one focused on primary care and the other on post-acute care.
The Washington Post reported the administration was “closing in” on the choice, citing unnamed sources. Still, the White House declined to comment and he could face opposition from Senate Democrats.
The agency is mulling the types of information medtechs might include in labeling for such devices to support transparency. A Philips rep worried about the pitfalls of “information overload.”
But the committee members remain opposed to broad use of boosters in healthy young adults, for whom the benefits of an additional shot are less clear.
Results suggested Pfizer’s and Moderna’s vaccines may serve as a more potent booster for those who initially received Johnson & Johnson’s shot, although data are limited and preliminary.
Thursday’s investment hikes Walgreens’ stake in VillageMD from 30% to 63% as the pharmacy operator looks to increases its presence in the red-hot primary care market.
The closing news is likely to anger hospital groups, which have raised concerns the deal could hurt health IT competition and give UnitedHealthcare an unfair advantage in contract negotiations. DOJ is investigating the deal.